The Value of Anti-Mullerian Hormone as a Prognostic Indicator for Successful Live Birth Outcomes in Patients Experiencing Recurrent Pregnancy Loss.

MLA

Dahash, Manar Kadhim, et al. “The Value of Anti-Mullerian Hormone as a Prognostic Indicator for Successful Live Birth Outcomes in Patients Experiencing Recurrent Pregnancy Loss.” Journal of Obstetrics, Gynecology & Cancer Research, vol. 9, no. 4, July 2024, pp. 428–34. EBSCOhost, https://doi.org/10.30699/jogcr.9.4.428.

APA

Dahash, M. K., Al-Turaihi, A. M., Alkhafaji, Q. A. M., & Al Musawi, B. J. M. (2024). The Value of Anti-Mullerian Hormone as a Prognostic Indicator for Successful Live Birth Outcomes in Patients Experiencing Recurrent Pregnancy Loss. Journal of Obstetrics, Gynecology & Cancer Research, 9(4), 428–434. https://doi.org/10.30699/jogcr.9.4.428

Chicago

Dahash, Manar Kadhim, Azhar Mousa Al-Turaihi, Qays A. M. Alkhafaji, and Bushra Jawed Majeed Al Musawi. 2024. “The Value of Anti-Mullerian Hormone as a Prognostic Indicator for Successful Live Birth Outcomes in Patients Experiencing Recurrent Pregnancy Loss.” Journal of Obstetrics, Gynecology & Cancer Research 9 (4): 428–34. doi:10.30699/jogcr.9.4.428.